PROBIOTICS

Biopolis has capabilities from sourcing and screening of novel strains, to preclinical and clinical evaluation, scale-up and industrial manufacturing of probiotics. The Company has developed both proprietary and tailored strains for its partners infant nutrition and produces several tons of probiotics every year.

NOVEL INGREDIENT DEVELOPMENT & EVALUATION

Activities in this Unit are based in the use of the Caenorhabditis elegans preclinical model for the evaluation of novel food and pharmaceutical active ingredients.  Biopolis has developed proprietary functional ingredients and probiotics and has helped its partners in the development of their own products.

CELL FACTORIES

We offer R&D services to the Chemical and Pharmaceutical industries. We are specialized in microbial strain and bioprocess design and development, including fermentation and downstream set-up and optimization, for the overproduction of valuable metabolites, such as proteins, specialized sugars and biopolymers.

QUALITY

CERTIFICATION POLICY

Biopolis manufacturing facility follows GMP practices and has received ISO 9001:2008, ISO 22000:2005, ISO 14001:2015, UNE 166002:2014 and HALAL certifications.

We are currently seeking OHSAS 18001, GMP Cell Factories, KOSHER and EFR certifications.

Our main strategic goal is to become a 5-STAR EXCELLENCE CERTIFIED by 2020.

Our Current Certifications

Our next moves

R & D track-record

LEARN MORE ABOUT